Integromics Hires New CEO, Eyes Next-Generation Sequence Analysis Market

New CEO Michael McManus said the company will have a clear focus on the next-generation sequence market but will also continue to develop tools for its microarray, qPCR, and proteomics customers.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.